Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

The erectile dysfunction devices market has been experiencing swift growth, driven by a variety of health, demographic, and technological factors. This market is poised for continued expansion as awareness rises and new treatment options become more accessible worldwide. Let’s explore the current market size, key growth drivers, segmentation, emerging trends, and leading players shaping the future of this sector.

Steady Market Expansion Projected for the Erectile Dysfunction Devices Market

The erectile dysfunction devices market is on a rapid growth trajectory, increasing from $2.09 billion in 2025 to $2.35 billion in 2026, supported by a compound annual growth rate (CAGR) of 12.3%. This upward trend is largely attributed to factors such as the growing prevalence of diabetes, rising cases of cardiovascular diseases, an aging male population, heightened awareness about erectile dysfunction therapies, and broader availability of urology care services. Looking ahead, this market is expected to reach $3.73 billion by 2030, maintaining the same CAGR of 12.3%. The anticipated growth during this period is fueled by a rise in lifestyle-related disorders, increasing focus on male health awareness, greater acceptance of medical devices for sexual health, wider access to minimally invasive treatments, and ongoing improvements in healthcare infrastructure, especially in emerging markets.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18813&type=smp

Key Factors Boosting the Erectile Dysfunction Devices Industry

One significant driver propelling the market is the rising incidence of prostate cancer. This cancer originates in the prostate gland, a small male organ involved in semen production. Increasing prostate cancer cases stem from aging populations, better diagnostic tools, and lifestyle shifts that contribute to the disease’s prevalence. After treatment, prostate cancer patients often face erectile dysfunction, making erectile dysfunction devices crucial for restoring sexual function and enhancing quality of life. For instance, in September 2025, the American Cancer Society projected approximately 313,780 new prostate cancer cases in the United States alone. The risk of prostate cancer escalates with age, climbing from 0.2% in men under 50 to 6.5% in those aged 70 to 79. This growing prevalence plays a vital role in driving demand for erectile dysfunction devices.

Additional Elements Encouraging Market Growth

Beyond prostate cancer, factors such as increasing male health consciousness and broader acceptance of sexual health devices are fueling market expansion. The willingness to adopt medical solutions for erectile dysfunction, including non-invasive and surgical options, is on the rise. Furthermore, advancements in minimally invasive treatments and improved healthcare access in developing regions are creating new growth opportunities for companies operating in this space.

Access The Complete Erectile Dysfunction Devices Market Report:

https://www.thebusinessresearchcompany.com/report/erectile-dysfunction-devices-global-market-report

A Closer Look at Erectile Dysfunction Devices Market Segmentation

This market is categorized based on device type, causes, approach, age group, and end-user segments. Device types are split into non-surgical and surgical devices. Causes include diabetes, neurological disorders, hypertension, and other factors influencing erectile dysfunction. Approaches are divided into invasive and non-invasive methods. Age groups considered are under 40 years, 40 to 60 years, and over 60 years. Finally, end-users encompass hospitals, clinics, ambulatory surgical centers, and other healthcare facilities.

Breaking down device types further, non-surgical devices include penile pumps (vacuum erection devices), external penile prostheses, erectile dysfunction medications (oral and topical), penile traction devices, and intraurethral suppositories. Surgical options cover penile implants (inflatable and semi-rigid), penile prostheses (inflatable and non-inflatable), and vascular surgery devices such as penile artery surgery tools.

Emerging Trends Shaping the Erectile Dysfunction Devices Market

Innovation is a major focus for market leaders who are developing advanced, non-invasive erectile dysfunction devices to stay competitive. These devices aim to improve erectile function without requiring surgery, often using technology like vacuum therapy or electrical stimulation. For example, in June 2024, Ohh-Med Medical, based in Israel, introduced the VerticaPlus device. This cutting-edge solution integrates a cloud-based mobile app that enhances therapy by providing real-time feedback, quality tracking, and personalized coaching throughout treatment. Such innovations are making erectile dysfunction management more effective and user-friendly.

Additional Innovations Highlighting Industry Progress

The integration of digital health technologies, such as mobile applications and cloud computing, is revolutionizing treatment experiences. These advancements allow patients to receive customized guidance, monitor progress, and adjust therapy settings conveniently, which can improve overall treatment adherence and outcomes. Increasingly, manufacturers are focusing on products that combine medical efficacy with user engagement tools.

Leading Industry Players in the Erectile Dysfunction Devices Market

Several prominent companies dominate this field, including Boston Scientific Corporation, Coloplast Corporation, MTS Medical AG, Alma Lasers Ltd., Shenzhen Huikang Medical Apparatus Co Ltd, Storz Medical AG, UroMatrix Medical Systems, Medispec Ltd., Zephyr Surgical Implants, Timm Medical Technologies Inc., Promedon GmbH, Zimmer MedizinSysteme GmbH, Rigicon Inc., NOVAmedtek, Vacurect, The Elator, Silimed Indústria de Implantes, Restore Medical Inc, Medtronic plc, Titan Medical Inc, and Encore Medical Ltd. These organizations are actively investing in research and development to expand their product portfolios and address evolving patient needs.

Regional Insights and Market Growth Across Geographies

In 2025, North America held the largest share of the erectile dysfunction devices market. Meanwhile, the Asia-Pacific region is projected to experience the fastest growth throughout the coming years. Other key regions analyzed in the market report include South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of global market dynamics and expansion opportunities.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model